Science
Tirzepatide vs Retatrutide
REPRIME Research·26 Jan 2026·7 min read
A side-by-side framing of two of the most discussed research peptides — their structural differences, their receptor footprints, and what that means for laboratory work.
Both tirzepatide and retatrutide originated from the same research lineage but differ structurally in ways that shape their receptor activity. This article steps through the comparison.
Receptor footprint
Tirzepatide acts on the GLP-1 and GIP receptors. Retatrutide adds the glucagon receptor — making it the first triple-agonist of its class.
Implications for laboratory protocols
The distinction is not academic: researchers designing comparative protocols benefit from understanding what each compound binds and at what affinity. Always read the COA before reconstitution.
← Back to journal© REPRIME